Stroke prevention device misses key goal in study

March 9, 2013 by Marilynn Marchione

The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.

Early results from a key study of Boston Scientific Corp.'s Watchman device suggest it is safer than previous testing suggested, but may not be as good as a drug that is used now for preventing strokes, heart-related deaths and in people with atrial . That condition causes the heart to flutter rather than beat as it should, which can lead to clots that cause strokes.

The results were to have been the top study at an American College of Cardiology conference in San Francisco on Saturday but the presentation was pulled because the company released results early.

Explore further: Bristol-Pfizer anticlot drug gets key EU approval

shares

Related Stories

Bristol-Pfizer anticlot drug gets key EU approval

November 20, 2012
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.

Stroke-preventing technology demonstrated in JoVE

February 28, 2012
In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million Americans will be ...

FDA clears anticlotting drug Eliquis

December 28, 2012
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.